Search Results

You are looking at 121 - 130 of 653 items for :

  • "surveillance" x
Clear All
Full access

Nishant Patel, Adam C. Yopp and Amit G. Singal

rates near 70% with resection or liver transplantation, whereas those with advanced HCC have a median survival of less than 1 year. 2 Surveillance at 6-month intervals is recommended in patients with cirrhosis and is associated with improved early

Full access

En Cheng, Peiyin Hung and Shi-Yi Wang

of HCC, it is critical to investigate geographic variations in HCC curative treatments and their associations with survival among HCC patients. Methods: Analyzing the Surveillance, Epidemiology, and End Results (SEER)-Medicare database, we

Full access

Joseph J. Fantony and Brant A. Inman

Bladder cancer is the second most common malignancy of the genitourinary tract and fifth most common malignancy overall in the United States. 1 The current standard for diagnosis and surveillance of bladder cancer includes a combination of

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Shilpa Gupta, Steven L. Hancock, Jenny J. Kim, Timothy M. Kuzel, Elaine T. Lam, Clayton Lau, Ellis G. Levine, Daniel W. Lin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Elizabeth R. Plimack, Edward N. Rampersaud, Bruce G. Redman, Charles J. Ryan, Joel Sheinfeld, Brian Shuch, Kanishka Sircar, Brad Somer, Richard B. Wilder, Mary Dwyer and Rashmi Kumar

experience relapse. To prevent relapse in patients with stages IA and IB pure seminoma, the standard management options after initial orchiectomy include active surveillance, RT, or chemotherapy with 1 or 2 cycles of carboplatin. The disease-specific survival

Full access

Ju Dong Yang, Michael Luu, Amit G. Singal, Mazen Noureddin, Alexander Kuo, Walid S. Ayoub, Vinay Sundaram, Honore Kotler, Irene K. Kim, Tsuyoshi Todo, Georgios Voidonikolas, Todd V. Brennan, Kambiz Kosari, Andrew S. Klein, Andrew Hendifar, Shelly C. Lu, Nicholas N. Nissen and Jun Gong

satellite nodules or microscopic vascular invasion, 2 and therefore patients who present at this stage have an excellent prognosis. 3 , 4 Studies have shown that tumors detected under surveillance programs are associated with early-stage disease and

Full access

James L. Mohler

spawned new interest in active surveillance as an option for the management of clinically localized prostate cancer. In 2009, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer were the first cancer guidelines to

Full access

Robert J. Motzer, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Mark K. Buyyounouski, Michael A. Carducci, Sam S. Chang, Toni K. Choueiri, Shilpa Gupta, Steven L. Hancock, Gary R. Hudes, Eric Jonasch, Timothy M. Kuzel, Clayton Lau, Ellis G. Levine, Daniel W. Lin, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Thomas W. Ratliff, Bruce G. Redman, Cary N. Robertson, Charles J. Ryan, Joel Sheinfeld, Jue Wang and Richard B. Wilder

after initial orchiectomy include surveillance, radiotherapy, or chemotherapy with 1 or 2 cycles of carboplatin. The disease-specific survival for stage I disease is 99%, irrespective of the management strategy used. 16 Several prospective nonrandomized

Full access

Anne M. Covey

In an Italian study that compared 6- and 12-month surveillance, 15 the researchers found that 6-month surveillance increased detection of HCC amenable to curative treatment and improved OS (45 vs 30 months, respectively). Ability to Treat Once

Full access

Junmiao Wen and Donglai Chen

Institute , Bethesda, MD 20850 – 9765 . 3. National Cancer Institute . Surveillance, Epidemiology, and End Results . Radiation/Chemotherapy Databases ( 1975–2016 ). Accessed July 6, 2020. Available at: https://seer.cancer.gov/data/treatment.html 4

Full access

a new algorithm. OSTEO-4 Under “Surveillance”: 6th bullet was modified to include “Orthopedic and Oncologic.” BONE-A Under “Core Group”: “Musculoskeletal oncologist” was added and “surgical oncologist” was omitted